Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOF/GS-5816 in Chronic HCV Infection (China Phase 3)
CTR20160603Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sofosbuvir + velpatasvir in hepatitis C virus infection, sponsored by Gilead Sciences. Started Dec 2016; status: completed.
02
Drugs
sofosbuvir + velpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on CTR20160603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160603.